Option chain shows key data for Greenpro Capital's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Greenpro Capital.

Greenpro Capital (NASDAQ:GRNQ) Stock, Option Chain

Greenpro Capital

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

Charles Schwab shutter

News

Intraday Update

Markets

Movers

Trading Ideas

AEON

AMIX

ANGO

ARVN

ATGL

CGBS

CHGG

CMND

EGHT

EOSE

FATE

FNKO

GRNQ

GROM

KOSS

LCFY

MTCH

NAAS

NEGG

NTWK

PACB

RDDT

SANA

SCHW

SFBS

SHOP

SHPW

SILO

SPRC

TKLF

VRPX

ZENV

Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Trading Charts on a Display

Pre-Market Outlook

AREB

AVXL

CNTM

DATS

KRKR

OPEN

Qualigen Therapeutics, Inc. - Common Stock

QLGN

SIEB

UAVS

Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Penny Stocks

Small Cap

CHNR

CNVS

CSCO

ENGN

FROG

FSLY

INFA

MHUA

NNOX

ROMA

SOUN

TELO

TWLO

UPXI

Shares of  AppLovin Corporation (NASDAQ: APP) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial

Why AppLovin Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Greenpro Capital Corp

<ul>
<li>In a first-of-its-kind study, tirzepatide also alleviated heart failure symptoms and physical limitations</li>
<li>Patients on tirzepatide experienced improved exercise capacity, greater weight loss and reduced systemic inflammation</li>
<li>Lilly has initiated submissions for tirzepatide for the treatment of HFpEF and obesity to global regulatory agencies</li>
</ul>

Reported Saturday, Eli Lilly's Tirzepatide Cuts Heart Failure Risk By 38% In Adults With Heart Failure With Preserved Ejection Fraction (HFpEF) And Obesity

On Sunday, President-elect Donald Trump picked pro-Starlink Republican Brendan Carr as chairman of the Federal Communications Commission, or FCC.
What Happened: &#8220;Commissioner Carr is a warrior for Free Speech, and has fought against the regulatory Lawfare that has stifled Americans&#8217; Freedoms, and held back our Economy. He will end the regulatory onslaught that has been crippling America&#8217;s Job Creators and Innovators, and ensure that the FCC delivers for rural America,&#8221; Trump wrote in his statement. 
Carr, a vocal critic of big tech companies, wrote on X that he is &#8220;humbled and noted&#8221; to take on the role. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Thank you, President Trump! I am humbled and honored to serve as Chairman of the FCC. Now we get to work. &#x1f1fa;&#x1f1f8; <a href="https://t.co/MPyL2d38kT">pic.twitter.com/MPyL2d38kT</a>
&mdash; Brendan Carr (@BrendanCarrFCC) <a href="https://twitter.com/BrendanCarrFCC/status/1858311955024400868?ref_src=twsrc%5Etfw">November 18, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Carr wrote last week that &#8220;Facebook, Google, Apple, Microsoft, and others have played central roles in the censorship cartel,&#8221; adding that they must be &#8220;dismantled.&#8221;
Carr currently serves as the senior Republican on the FCC. The FCC is an independent U.S. government agency overseen by Congress and regulates interstate and international communications by radio, television, wire, satellite, and cable in all 50 states, the District of Columbia, and U.S. territories. 
Jessica Rosenworcel currently serves as the Chairperson of the Commission. 
Why It Matters: Carr is a strong supporter of Musk&#8217;s Starlink. He staunchly <a href="https://www.benzinga.com/news/24/09/40672229/starlink-ineligible-for-nearly-900m-in-subsidies-says-fcc-spacex-ceo-elon-musk-says-it-is-flat-out-l">opposed the FCC&#8217;s decision not to offer nearly $900 million in subsidies to Starlink</a> alleging that the FCC had added itself to the growing list of administrative agencies taking action against Musk's businesses following the billionaire's acquisition of Twitter (now X) on the instructions of President Joe Biden. 
Carr also said on Monday that the FCC will stop promoting Diversity, Equity, Inclusion, and Accessibility (DEI) initiatives.
&#8220;The FCC's most recent budget request said that promoting DEI was the agency's second-highest strategic goal. Starting next year, the FCC will end its promotion of DEI,&#8221; he wrote on X. 
Musk is also staunchly <a href="https://www.benzinga.com/news/24/04/38064076/mark-cuban-vows-to-defend-deis-positive-impact-on-business-because-they-are-opposite-of-elon-musk-an">opposed to DEI programs</a>, terming them &#8220;racist.&#8221; Musk regards preference for certain sections of the population in DEI programs as &#8220;racism&#8221; towards the majority white population. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/11/42025362/former-uber-executive-and-3-congressmen-contenders-for-trumps-transportation-chief-role-report">Former Uber Executive And 3 Congressmen Contenders For Trump&#8217;s Transportation Chief Role: Report</a></li>
</ul>
Photo courtesy: Gage Skidmore via Flickr

SPACE

Tech

Trump Names Pro-Starlink FCC Commissioner Brendan Carr As Chairperson, Says He Will 'End The Regulatory Onslaught'

<ul>
<li>Consistently rapid, deep and durable reduction in serum TTR accompanied by evidence of disease stabilization or improvement after a one-time treatment of nex-z, supporting the hypothesis that greater TTR reduction may lead to a greater clinical benefit in ATTR amyloidosis</li>
<li>Favorable trends consistently observed across multiple markers of cardiac disease progression at month 12 compared to baseline in an ATTR-CM population with a high proportion of advanced heart failure patients</li>
<li>Consistent trend observed to date in ATTRv-PN arm, with stability or improvement of neuropathy as measured by multiple clinical measures of disease progression compared to baseline</li>
<li>Persistently deep levels of serum TTR reductions following a single infusion remain virtually unchanged after two or more years of follow-up in over 25 patients</li>
<li>Favorable safety and tolerability profile observed</li>
<li>ATTR-CM data presented at the 2024 AHA Scientific Sessions and published in the New England Journal of Medicine</li>
</ul>

NTLA

Reported Saturday, Intellia Announced Initial Phase 1 Data Suggesting Nexiguran Ziclumeran, An In Vivo CRISPR/Cas9 Gene Editing Therapy, May Benefit ATTR Amyloidosis Progression

BMRN

Reported Saturday, BioMarin Presents Real-World Data On VOXZOGO Efficacy And Safety In Children With Achondroplasia At ESPE 2024

BioCryst Pharmaceuticals, Inc.&nbsp;(Nasdaq:&nbsp;BCRX) today announced that the Health Services Executive (HSE) in Ireland has recommended ORLADEYO&#xAE;&nbsp;(berotralstat) for the routine prevention of recurrent attacks of hereditary angioedema (HAE) in eligible patients 12 years and older. With this recommendation, HAE patients in Ireland will have access to the first oral, once-daily therapy for the reduction of recurrent HAE attacks.
"The positive HSE recommendation of ORLADEYO&nbsp;broadens access to modern prophylaxis, providing greater choice for prescribing physicians and potentially a better quality of life for HAE patients in Ireland," said Charlie Gayer, chief commercial officer of BioCryst.
The HSE decision in Ireland follows the European Commission marketing authorization of ORLADEYO in April 2021. To date, ORLADEYO is licensed in 44 countries.

Government

Regulations

BCRX

BioCryst's ORLADEYO Gets Ireland's Approval: Expanding Access to Once-Daily HAE Therapy

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation

Reported Saturday, Boston Scientific's WATCHMAN FLX Device Shows Superior Bleeding Risk Reduction Compared To Oral Anticoagulants After Cardiac Ablation In OPTION Clinical Trial

<ul>
<li>New preclinical results support the anti-fibrotic potential of engineered macrophages in multiple fibrosis models</li>
<li>Engineered TIM4-expressing macrophages correct defective&nbsp;efferocytosis in MASH, demonstrating potent anti-fibrotic activity&nbsp;</li>
</ul>

CARM

Reported Sunday, Carisma Therapeutics Unveils Preclinical Data On Engineered Macrophages For Liver Fibrosis Treatment At AASLD The Liver Meeting 2024

<ul>
<li>Single Dose of Nucresiran 300mg or Higher Led to Rapid Knockdown of Mean TTR Levels of Greater than 90% by Day 15 that was Sustained at Six Months&nbsp;</li>
<li>At These Doses, Peak Reduction of Mean TTR Levels of Greater than 96% were Achieved by Day 29 −</li>
<li>Data Support Potential for Biannual or Annual Subcutaneous Dosing, Representing a New Paradigm in the Treatment of ATTR Amyloidosis −</li>
<li>Encouraging Safety and Tolerability Observed −</li>
<li>Alnylam Continues to Expect to Share Phase 3 Development Plans in Q1 2025 –</li>
</ul>

ALNY

Reported Sunday, Alnylam Reported Interim Phase 1 Results For Nucresiran (ALN-TTRsc04), Demonstrating Rapid And Sustained TTR Reduction Lasting Six Months After A Single Dose

"The preclinical data presented at ACR Convergence underscore the exceptional potential of our targeted protein degradation strategy compared to kinase inhibition for both BTK and IRAK4, which are critical targets in inflammatory and autoimmune diseases, and support continued advancement of these drug candidates into clinical studies," said Arthur T. Sands, M.D., Ph.D., president and chief executive officer of Nurix. "These programs showcase the capability of Nurix's DELigase platform to generate potent best-in-class degrader drug candidates with the potential to deliver superior efficacy in several inflammatory diseases."

NRIX

Reported Sunday, Nurix Therapeutics Showcased Preclinical Data On NX-5948 And GS-6791 From Autoimmune And Inflammatory Disease Programs At ACR Convergence 2024

<ul>
<li>ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FRα) positive, platinum-resistant ovarian cancer</li>
<li>ELAHERE represents the first treatment to demonstrate an overall survival benefit in a Phase 3 trial in platinum-resistant ovarian cancer compared with chemotherapy</li>
<li>VENTANA FOLR1 (FOLR1-2.1)&nbsp;RxDx Assay, the companion diagnostic to identify ovarian cancer patients eligible for ELAHERE, also receives CE Mark</li>
</ul>

ABBV

AbbVie Secures European Commission Approval For ELAHERE, First Novel Therapy For Platinum-Resistant Ovarian Cancer

<ul>
<li>The VENTANA FOLR1 (FOLR1-2.1) RxDx Assay detects the folate receptor 1 protein (FOLR1 or FRɑ), which is over-expressed in most ovarian cancers.</li>
<li>The test identifies ovarian cancer patients eligible for targeted treatment with ELAHERE. &nbsp;</li>
<li>This certification follows the unprecedented decision by regulators to grant an early exemption approval for the test in Germany and Austria earlier this year.</li>
</ul>

RHHBF

RHHBY

Roche Secures CE Mark For VENTANA FOLR1 RxDx Assay, The First IHC Diagnostic For Identifying Epithelial Ovarian Cancer Patients Eligible For ELAHERE

<ul>
<li>Revere Medical Enters into Agreement to Acquire CareMax's Management Services Organization</li>
<li>Agreement in Principle Reached with "Stalking Horse" for Core Centers' Assets</li>
<li>Sale Transactions to be Implemented Through an Expedited Prearranged Chapter 11 Plan Supported by 100% of CareMax's Secured Lenders</li>
<li>CareMax Secures $30.5 Million in Debtor in Possession Financing to Support Operations and Continuing Provision of Healthcare Services Throughout Restructuring Process</li>
</ul>

CMAX

Reported Sunday, CareMax Enters Prearranged Chapter 11, Reaches Deal To Sell MSO And Core Centers' Assets, Secures $30.5M DIP Financing

Reported Sunday, Apollo Opens Seoul Office Amid APAC Expansion, Taps Samsung Securities Veteran Jay Hyun Lee As Head Of Korea

Alibaba intends to use the net proceeds from the offering of the Notes for general corporate purposes, including repayment of offshore debt and share repurchases.

BABA

Reported Sunday, Alibaba Announces Dual Currency Senior Unsecured Notes Offering, Targeting Capital Raise For Debt Repayment And Strategic Share Buybacks

In collaboration with Toronto Metropolitan University, the Government of Canada will invest $3.9M CAD in the Malaysia Cybersecurity Center of Excellence to strengthen cybersecurity partnerships and expertise in the region through skills training opportunities, including for women

Reported Sunday, Blackberry Partners With Canadian Government And TMU To Launch Cybersecurity Training Initiative In Southeast Asia With C$3.9M Investment

This milestone is further celebrated by the anticipated opening of twelve additional Four Points Flex by Sheraton properties across Japan this year, which will also mark the company's entry to key cities such as Morioka and Kanazawa. In collaboration with global investment firm KKR, this conversion-friendly expansion is expected to see a total of 14 properties join the brand in Japan through early 2025, adding over 3,600 rooms to Marriott's growing portfolio across prominent destinations including Hakodate, Utsunomiya, Yokohama, Nagoya, Osaka, Kyoto, Kobe, and Hakata.

Marriott International Marks Milestone With 100th Property In Japan, Launching Four Points Flex By Sheraton In Asia Pacific

Accenture Partners With ETS To Launch Global Skills-Based Talent Management Platform

Renowned tech investor and Palantir Technologies&#8217; co-founder&nbsp;Peter Thiel&nbsp;has made a daring prediction about the potential impact of President-elect Donald Trump&#8217;s <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41902202/trumps-china-hawks-rumored-for-top-roles-yuan-hits-3-month-low">60% tariff on Chinese goods</a>.
What Happened: On Thursday, during an interview with The Free Press, Thiel suggested that such a tariff would be &#8220;very, very bad&#8221; for <a href="https://www.benzinga.com/general/social-media/24/11/41912771/trump-presidency-magnificent-7-stock-impact-benzinga-readers-pick-tech-titan-at-most-risk-following-2024-election">Chinese companies</a> and China as a whole.
However, he believes the impact on American consumers would be &#8220;mildly negative&#8221; as manufacturing would likely shift away from China.
According to Thiel, shifting manufacturing from China to Vietnam would significantly harm China, and have only a minor impact on American consumers. From a geopolitical perspective, he argued, this move would align closely with American strategic interests.
See Also:&nbsp;<a href="https://www.benzinga.com/etfs/24/11/42018463/trumps-post-election-rally-fades-dollar-surges-to-over-1-year-highs-powell-puts-december-interest-rate-cut-into-question-this-week-in-the-market?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump&#8217;s Post-Election Rally Fades, Dollar Surges To Over 1-Year Highs, Powell Puts December Interest Rate Cut Into Question: This Week In The Market</a>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Peter Thiel on the Triumph of the Counter-Elites" width="500" height="281" src="https://www.youtube.com/embed/wwJV_NuN43Y?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Why It Matters: Earlier this year, Chinese stocks <a href="https://www.benzinga.com/markets/asia/24/05/38782459/china-focused-etfs-have-become-political-footballs-in-us-as-investor-apprehension-leads-to-large-sca#google_vignette">experienced a notable rally</a>, pushing the SSE Composite Index in Shanghai to its highest point since September 2023.
However, Trump's proposed tariffs, which could reach as high as 60% on Chinese goods, along with additional import hikes on other nations, could disrupt these investments.
A day after Trump won, China-linked ETFs witnessed a sharp fall after rallying for nearly two months.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>China-linked ETFs</td>
<td>Share Price Drop On Nov. 6, 2024</td>
</tr>
<tr>
<td>KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>)</td>
<td>2.01%</td>
</tr>
<tr>
<td>iShares MSCI China ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHI#NASDAQ">MCHI</a>)</td>
<td>2.70%</td>
</tr>
<tr>
<td>iShares China Large-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NYSE">FXI</a>)</td>
<td>2.94%</td>
</tr>
</tbody>
</table>
</figure>
U.S.-listed Chinese stocks such as Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>), and XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) also <a href="https://www.benzinga.com/government/24/11/41773691/us-listed-chinese-stocks-like-alibaba-jd-nio-fall-after-trumps-win-whats-going-on">saw a decline in trading</a> following Trump&#8217;s win.
The imposition of such tariffs could strain China's economic growth, negatively impacting the performance of <a href="https://www.benzinga.com/general/social-media/24/11/41912771/trump-presidency-magnificent-7-stock-impact-benzinga-readers-pick-tech-titan-at-most-risk-following-2024-election">China-focused ETFs</a>, particularly those tied to the tech sector and large-cap companies, making them less attractive to investors.
Despite the immediate economic challenges that such a tariff would pose, some experts believe that China may view Trump's return to the White House as <a href="https://www.benzinga.com/news/global/24/11/41870809/china-may-benefit-from-trumps-return-to-white-house-despite-his-tariff-plans-says-expert-short-term-pain-but-potentially-long-term-strategic-gain">an opportunity for strategic advantage</a>.
Earlier this week, Chinese President Xi Jinping also expressed China's willingness to <a href="https://www.benzinga.com/24/11/42025284/xi-jinping-tells-joe-biden-china-is-ready-to-work-with-trump-as-tariff-threat-looms">collaborate with the U.S. government</a>, regardless of the administration in power.
Image via Wikimedia
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/41998910/mohamed-el-erian-criticizes-fed-chair-powells-interview-performance-says-responses-left-many-perplexed?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mohamed El-Erian Criticizes Fed Chair Powell&#8217;s Interview Performance: &#8216;He Struggled With Some Of The Smart Questions&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Politics

Economics

BIDU

KWEB

MCHI

XPEV

Peter Thiel Says Trump's 60% China Tariff Would Be 'Very, Very Bad' For Beijing, Here's What's At Stake

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is trading over 5% on Robinhood&#8217;s overnight trading service after a report on Sunday, suggested that the upcoming regulatory framework might ease mandates for self-driving vehicles. 
What Happened: The transition team of President-elect Donald Trump has told advisors that it aims to make a framework for fully self-driving vehicles a priority for the Transportation Department, <a href="https://www.bloomberg.com/news/articles/2024-11-17/trump-team-said-to-want-to-ease-us-rules-for-self-driving-cars">reported</a> Bloomberg, citing people familiar with the matter. 
Tesla CEO Elon Musk recently secured a position to lead the newly created Department of Government Efficiency (DOGE) in the Trump administration, supported federal rules for autonomous vehicles in Tesla&#8217;s third-quarter earnings call, saying he would use any role to push the government to allow autonomous vehicles to be used nationwide. 
National Highway Traffic Safety Administration allows automakers to deploy only 2,500 autonomous vehicles per year, while efforts to increase this number have repeatedly failed. 
See Also: <a href="https://www.benzinga.com/24/11/42028342/blackwell-backfires-nvidias-ai-chips-struggle-with-server-overheating-impacting-meta-microsoft-and-musks-xai-data-centers">Nvidia&#8217;s Blackwell Chips Are Extra Toasty, Server Overheating Issues Impact Meta, Microsoft And Elon Musk&#8217;s xAI</a>
Why It Matters: In October, Musk unveiled Tesla&#8217;s long-awaited robotaxi, which aims to mass produce &#8216;Cybercabs&#8217; by 2026. Investors and market analysts are considering robotaxi&#8217;s success as a major factor for the company&#8217;s valuation, while some investors remain skeptical about <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41444334/tesla-robotaxi-reveal-falls-flat-amid-lack-of-clarity-shifting-focus-back-on-elon-m">robotaxi&#8217;s success in regulatory approval</a>. 
In October, ARK Investment Management said that Tesla&#8217;s driverless ride-hailing plans could unlock $11 trillion in revenue potential, exceeding the total addressable market <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41593922/cathie-woods-ark-invest-sees-tesla-unlocking-11-trillion-revenue-potential-with-rob">that ride-hailing companies</a> Uber Technologies Inc. and LYFT Inc. are targeting.
The Future Fund&nbsp;Managing Partner&nbsp;Gary Black has repeatedly voiced skepticism about&nbsp;Tesla maintaining a monopoly in the unsupervised autonomy market, citing competition from Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)-backed Waymo, Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) and Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) who has already received approval to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40333845/gary-black-highlights-skepticism-over-teslas-autonomy-ambitions-amid-competition-fr">deploy their autonomous vehicles</a>.
Price Action: Tesla is trading 5.69% higher at $339 on Robinhood&#8217;s overnight trading service. The stock closed at $320.72 in a regular trading session on Friday, gaining 3.07% for the day. In after-hours trading, the stock edged up 0.0062%. Year to date, Tesla's stock has risen by 29.10%, according to&nbsp;<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/24/11/42022443/ibm-disney-and-other-large-advertisers-return-to-elon-musks-x-after-a-year-long-boycott-we-super-appreciate" target="_blank" rel="noreferrer noopener">IBM, Disney And Other Large Advertisers Return To Elon Musk's X After A Year-Long Boycott: ‘We Super Appreciate'</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

GOOG

GOOGL

MBLY

TSLA

Tesla Soars Over 5% In Overnight Trading As Trump Administration Reportedly Seeks To Ease FSD Norms

Gita Gopinath, Deputy Managing Director of the International Monetary Fund, expressed concern over the increasing energy consumption and carbon footprint of cryptocurrency mining and AI data centers, expected to worsen in the next few years.
What Happened: In an X post on Sunday, Gopinath stated, citing IMF data, that the share of cryptocurrency mining and data centers in global electricity could rise to 3.5% by 2027 in a base case scenario, from 2% in 2022. This would equate to the current consumption of Japan, the world&#8217;s fifth-largest electricity user.
In the high-case scenario, the share could expand to nearly 6%, while the low-case scenario would see a slight increase to 2.2%.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Crypto mining and data centers together accounted for 2 percent of world electricity demand in 2022. And that share is likely to climb to 3.5 percent in three years. That would be equivalent to current consumption of Japan, the world's fifth largest electricity user. Read more… <a href="https://t.co/yOfHoO32dA">pic.twitter.com/yOfHoO32dA</a>
&mdash; Gita Gopinath (@GitaGopinath) <a href="https://twitter.com/GitaGopinath/status/1858210326204100884?ref_src=twsrc%5Etfw">November 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Interestingly, cryptocurrency mining activity&#8217;s share in global CO₂ emissions was projected to decline in 2027, primarily driven by the reduction in mining rewards <a href="https://www.benzinga.com/money/what-is-bitcoin-halving">due to halving</a>. However, data centers&#8217; carbon emissions could reach 450 million tons by 2027, or 1.2% of the world&#8217;s total.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42028523/cathie-wood-draws-reagan-era-parallels-as-elon-musk-takes-doge-helm-this-bull-market-has-just-begun-to-broaden-out">Cathie Wood Draws Reagan-Era Parallels As Elon Musk Takes DOGE Helm: &#8216;This Bull Market Has Just Begun To Broaden Out&#8217;</a>
Why It Matters: Gopinath&#8217;s concerns come amid the ongoing debate around Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) mining's environmental impact
According to the Cambridge Bitcoin Electricity Consumption Index, the annual greenhouse emissions from Bitcoin mining were&nbsp;<a href="https://ccaf.io/cbnsi/cbeci/ghg/comparisons" target="_blank" rel="noreferrer noopener">higher&nbsp;</a>than in countries like Greece and North Korea.
However, the increasing footprint hasn&#8217;t deterred nations from exploring the economic prospects associated with the still-nascent business.
President-elect Donald Trump vowed to make the <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39363038/donald-trump-speaks-on-bitcoin-mining-wants-all-the-remaining-bitcoin-to-be-made-in-the-us">U.S. the Bitcoin mining hub of the world</a> during his election campaign, while Vladimir Putin&#8217;s Russia <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40279474/putin-greenlights-crypto-mining-in-russia-2-months-after-trump-vowed-to-mine-all-remaining">legalized cryptocurrency mining</a> earlier this year.
Photo by CMP_NZ on Shutterstock
Photo Courtesy: Shutterstock.com
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42027183/michael-saylor-predicts-bitcoin-boom-says-100k-on-the-horizon">Michael Saylor Predicts Bitcoin Boom, Says $100K On The Horizon</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Core Scientific, Inc. - Class A Common Stock

CORZ

Gita Gopinath Of IMF Alarmed By Crypto And AI Energy Use, Says Share Expected To Match Japan's Current Power Consumption In Just 3 Years

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Greenpro Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) just reported results for the fourth quarter of 2023.<ul><li>Greenpro Capital reported earnings per share of -71 cents.</li><li>The company reported revenue of $1.17 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/03/grnq-stock-earnings-greenpro-capital-for-q4-of-2023/">GRNQ Stock Earnings: Greenpro Capital Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

GRNQ Stock Earnings: Greenpro Capital Reported Results for Q4 2023

Greenpro Capital announces approval of gold backed security token - DIGau

Greenpro Capital Corp (GRNQ) has shared an announcement. Christophe Philippe Roland Bringuier, an independent director of Greenpro Capital Corp., h...

Greenpro Capital Announces Independent Director's Resignation

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Greenpro Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) just reported results for the first quarter of 2024.<ul><li>Greenpro Capital reported earnings per share of -4 cents.</li><li>The company reported revenue of $658,399.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/grnq-stock-earnings-greenpro-capital-for-q1-of-2024/">GRNQ Stock Earnings: Greenpro Capital Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

GRNQ Stock Earnings: Greenpro Capital Reported Results for Q1 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!



Moving stocks are new agreements, a patent, a public offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>SILO Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/silo-stock-quote/">SILO</a>) stock is rocketing more than 69% after <a href="https://www.nasdaq.com/press-release/silo-pharma-secures-exclusive-global-license-alzheimers-therapeutic-2024-07-16">securing a new license</a>.</li>



<li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) shares are soaring over 65% with heavy pre-market trading.</li>



<li>SciSparc (NASDAQ:<a href="https://investorplace.com/stock-quotes/sprc-stock-quote/">SPRC</a>) stock is surging more than 39% on a <a href="https://www.nasdaq.com/press-release/scisparc-announces-us-patent-application-treating-metabolic-syndrome-and-weight-loss">new weight loss patent</a>.</li>



<li>Meiwu Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/wnw-stock-quote/">WNW</a>) shares are rising over 30% with strong early morning trading.</li>



<li>Singing Machine (NASDAQ:<a href="https://investorplace.com/stock-quotes/mics-stock-quote/">MICS</a>) stock is increasing more than 25% on a <a href="https://www.nasdaq.com/press-release/singing-machines-subsidiary-semicab-announces-over-9-million-contracted-revenue">$9 million revenue backlog contract</a>.</li>



<li>Passage Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/pasg-stock-quote/">PASG</a>) shares are gaining over 18% on <a href="https://www.nasdaq.com/press-release/passage-bio-announces-positive-feedback-fda-expansion-uplift-d-trial-pbft02-include">clinical trial expansion feedback</a>.</li>



<li>AEON Biopharma (NYSEMKT:<a href="https://investorplace.com/stock-quotes/aeon-stock-quote/">AEON</a>) stock is climbing more than 16% with strong pre-market trading.</li>



<li>Shineco (NASDAQ:<a href="https://investorplace.com/stock-quotes/sisi-stock-quote/">SISI</a>) shares are getting an over 12% boost after <a href="https://www.stocktitan.net/news/SISI/shineco-announces-closing-of-2-million-underwritten-public-r9iot7ulzqfp.html">closing a public offering</a>.</li>



<li>SMX (Security Matters) (NASDAQ:<a href="https://investorplace.com/stock-quotes/smx-stock-quote/">SMX</a>) stock is jumping more than 11% <a href="https://www.nasdaq.com/press-release/smx-announces-effective-date-reverse-stock-split-2024-07-11">following a reverse stock split</a>.</li>



<li>Biomerica (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmra-stock-quote/">BMRA</a>) shares are up over 11% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Autonomix Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/amix-stock-quote/">AMIX</a>) stock is diving more than 18% <a href="https://www.nasdaq.com/press-release/autonomix-enters-definitive-agreement-license-intellectual-property-fda-cleared">following a rally yesterday</a>.</li>



<li>Vince (NYSE:<a href="https://investorplace.com/stock-quotes/vnce-stock-quote/">VNCE</a>) shares are tumbling over 17% without any clear news this morning.</li>



<li>TuanChe (NASDAQ:<a href="https://investorplace.com/stock-quotes/tc-stock-quote/">TC</a>) stock is taking a more than 17% beating on Tuesday morning.</li>



<li>Greenpro Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) shares are sliding over 17% after <a href="https://www.nasdaq.com/press-release/greenpro-capital-corp-and-green-x-corp-forms-strategic-alliance-bank-islam-trust">rising yesterday on a strategic alliance</a>.</li>



<li>Lottery.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/ltry-stock-quote/">LTRY</a>) stock is dropping more than 16% on Tuesday.</li>



<li>Vicinity Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/vev-stock-quote/">VEV</a>) shares are decreasing over 16% this morning.</li>



<li>Tantech (NASDAQ:<a href="https://investorplace.com/stock-quotes/tanh-stock-quote/">TANH</a>) stock is falling more than 15% despite a lack of news this morning.</li>



<li>MF International (NASDAQ:<a href="https://investorplace.com/stock-quotes/mfi-stock-quote/">MFI</a>) shares are slipping over 14% on Tuesday morning.</li>



<li>Cyngn (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/">CYN</a>) stock is dropping close to 14% <a href="https://www.benzinga.com/news/24/07/39781479/cyngn-shares-were-up-by-more-than-50-whats-going-on">after a recent rally</a>.</li>



<li>Lixiang Education (NASDAQ:<a href="https://investorplace.com/stock-quotes/lxeh-stock-quote/">LXEH</a>) shares close out our pre-market stock movers down more than 12% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-16th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Greenpro Capital&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) stock is dropping on Tuesday after the financial consulting and corporate advisory services company&rsquo;s shares underwent a large rally during the prior day of trading.



This saw shares of GRNQ stock close out normal trading hours on Monday up more than 34%. That came with heavy trading as over 10 million units moved yesterday. To put that number in perspective, the daily average trading volume for Greenpro Capital shares is around 183,000.



This rally didn&rsquo;t come without any news. The catalyst behind it was Greenpro Capital announcing a new strategic partnership. This brings together Greenpro Capital, its subsidiary Green-X and Bank Islam Trust Company.



Greenpro Capital CEO Dr. CK Lee <a href="https://www.nasdaq.com/press-release/greenpro-capital-corp-and-green-x-corp-forms-strategic-alliance-bank-islam-trust">said this about the strategic alliance</a>.




&ldquo;We are extremely excited to have&nbsp;Bank Islam Trust&nbsp;as our strategic partner to penetrate the Muslim and&nbsp;Middle East&nbsp;communities. There is a huge demand for digital asset investments from the&nbsp;Middle East, and we will structure our STO and RWA assets as alternative investment products to cater to their demand.&rdquo;




<h2>GRNQ Stock Movement Today</h2>



Considering the rally yesterday, it makes sense that GRNQ stock would give up some of those gains today. That has the stock falling 19.1% as of Tuesday morning. Traders will note that GRNQ shares were down 5.6% year-to-date when markets closed yesterday.



Today&rsquo;s stock market movement comes with some 230,000 shares of GRNQ on the move. That&rsquo;s already above Greenpro Capital&rsquo;s daily average trading volume.



Investors will want to keep reading for more of the biggest stock market stories on Tuesday!



We have all of the hottest stock market happenings to report on today! That includes the latest news for Autonomix Medical&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/amix-stock-quote/">AMIX</a>) stock, Conduit Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) stock and Silo Pharma&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/silo-stock-quote/">SILO</a>) stock this morning. All of this info is ready to go at the links below!



<h2>More Stock Market News for Tuesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-autonomix-medical-amix-stock-down-17-today/">Why Is Autonomix Medical (AMIX) Stock Down 17% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-conduit-pharmaceuticals-cdt-stock-up-73-today/">Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-silo-pharma-silo-stock-up-123-today/">Why Is Silo Pharma (SILO) Stock Up 123% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-greenpro-capital-grnq-stock-down-19-today/">Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
SciSparc (NASDAQ:<a href="https://investorplace.com/stock-quotes/sprc-stock-quote/">SPRC</a>) stock is up on Tuesday after the clinical-stage pharmaceutical company <a href="https://finance.yahoo.com/news/scisparc-announces-u-patent-application-100300054.html">announced a new patent</a> application covering its weight loss treatment.



SciSparc notes that this patent covers the company&rsquo;s collaboration with Clearmind Medicine (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmnd-stock-quote/">CMND</a>). This is a clinical-stage biotech company focused on psychedelic-derived therapeutics.



This patent covers the novel proprietary composition of Palmitoylethanolamide. This is the active ingredient in SciSparc&rsquo;s proprietary CannAmide. It&rsquo;s used alongside Clearmind Medicine&rsquo;s MEAI compound to treat metabolic syndrome and obesity.



Here&rsquo;s what SpcSparc had to say about the new patent.




&ldquo;Overall, as part of this collaboration, twelve other patent applications have been filed by Clearmind with the USPTO for various compositions, including the proprietary composition of SciSparc&rsquo;s PEA with Clearmind&rsquo;s MEAI compound for the treatments of alcohol use disorder, cocaine addiction and obesity and its related metabolic disorders.&rdquo;




<h2>What This Means for SPRC Stock</h2>



SciSparc could reach a large market with its obesity treatment. The Centers for Disease Control and Prevention (<a href="https://investorplace.com/stock-quotes/cdc-stock-quote/">CDC</a>) estimates that 41.9% of adults over the age of 20 are obese. This saw the market reach $15 billion in 2022.



SPRC stock is up 24.6% as of Tuesday morning. This comes with some 37 million shares traded. That&rsquo;s well above its daily average trading volume of about 138,000 shares.



Investors will want to stick around for more of the most recent stock market stories today!



We have all of the hottest stock market news traders need to know about on Tuesday! Among that is what has shares of Match Group&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mtch-stock-quote/">MTCH</a>), Greenpro Capital&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) and Autonomix Medical&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/amix-stock-quote/">AMIX</a>) stock moving today. You can read all about that at the links below!



<h2>More Tuesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/mtch-stock-alert-activist-starboard-value-is-betting-big-on-match-group/">MTCH Stock Alert: Activist Starboard Value Is Betting Big on Match Group</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-greenpro-capital-grnq-stock-down-19-today/">Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-autonomix-medical-amix-stock-down-17-today/">Why Is Autonomix Medical (AMIX) Stock Down 17% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-scisparc-sprc-stock-up-25-today-july-16th/">Why Is SciSparc (SPRC) Stock Up 25% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is SciSparc (SPRC) Stock Up 25% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Palantir Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/pltr-stock-quote/">PLTR</a>) stock is in the news Tuesday as Mizuho analysts have issued a warning for the big data company&rsquo;s shares.



Mizuho analyst Gregg Moskowitz <a href="https://seekingalpha.com/news/4124573-palantir-slips-pre-market-following-ratings-downgrade-from-mizuho">downgraded PLTR stock</a> from a &ldquo;neutral&rdquo; rating to an &ldquo;underperform&rdquo; rating. To put that in perspective, the analysts&rsquo; consensus rating for PLTR is reduce based on 15 opinions.



Despite this downgrade, the Mizuho analyst did increase his price target for PLTR from $21 per share to $22 per share. This is a potential downside of 23.3% from the stock&rsquo;s prior closing price. It&rsquo;s also above the analysts&rsquo; consensus price prediction of $21.32 per share.



<h2>What&rsquo;s Behind the PLTR Stock Downgrade?</h2>



Here&rsquo;s what Moskowitz had to say about Palantir Technologies in a note to clients obtained by Seeking Alpha.




&ldquo;But primarily, following the material 67% rise in the shares YTD, we find it increasingly difficult to justify PLTR&rsquo;s high multiple (21x CY25E revenue) that, in our view, likely already discounts significant acceleration versus our consensus expectations for 20-21% revenue growth.&rdquo;




PLTR stock is down 2.3% as of Tuesday morning. The shares are up 68.9% since the start of the year.



Investors will want to stick around for more of the most recent stock market stories!



We have all of the hottest stock market news investors need to know about on Tuesday! A few examples include what&rsquo;s going on with shares of SciSparc&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/sprc-stock-quote/">SPRC</a>), Match Group&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mtch-stock-quote/">MTCH</a>) and Greenpro Capital&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) stock. You can catch up on all of this news at the links below!



<h2>More Stock Market News for Tuesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-scisparc-sprc-stock-up-25-today-july-16th/">Why Is SciSparc (SPRC) Stock Up 25% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/mtch-stock-alert-activist-starboard-value-is-betting-big-on-match-group/">MTCH Stock Alert: Activist Starboard Value Is Betting Big on Match Group</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-greenpro-capital-grnq-stock-down-19-today/">Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/mizuho-just-issued-a-warning-on-palantir-pltr-stock/">Mizuho Just Issued a Warning on Palantir (PLTR) Stock</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Mizuho Just Issued a Warning on Palantir (PLTR) Stock

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning!



Moving stocks are merger plans, a new contract, a CEO departure and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Gabelli Multi-Media Trust Inc. (The) Rights (expiring July 22, 2024) Rights (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GGTR#NYSE">GGTR</a>) stock is rocketing 110% as the <a href="https://www.nasdaq.com/press-release/gabelli-multimedia-trust-alerts-common-stock-shareholders-rights-offering-expiration">rights offering expiration date closes in</a>.</li>



<li>Aditxt (NASDAQ:<a href="https://investorplace.com/stock-quotes/adtx-stock-quote/">ADTX</a>) shares are soaring more than 79% on an <a href="https://www.nasdaq.com/press-release/aditxt-and-evofem-amend-and-restate-merger-agreement-targeting-september-30-closing">amended merger agreement</a>.</li>



<li>Shimmick (NASDAQ:<a href="https://investorplace.com/stock-quotes/shim-stock-quote/">SHIM</a>) stock is surging over 56% on a <a href="https://www.marketwatch.com/story/shimmick-shares-surge-on-27-6-million-california-contract-121fe14b?mod=investing">$27.6 million contract</a>.</li>



<li>Aura Fat Projects (NASDAQ:<a href="https://investorplace.com/stock-quotes/afar-stock-quote/">AFAR</a>) shares are gaining more than 33% without any clear news this morning.</li>



<li>MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) stock is increasing over 22% with heavy pre-market trading.</li>



<li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) shares are rising more than 18% with strong pre-market trading.</li>



<li>GitLab (NASDAQ:<a href="https://investorplace.com/stock-quotes/gtlb-stock-quote/">GTLB</a>) stock is climbing close to 16% higher on <a href="https://finance.yahoo.com/news/exclusive-google-backed-software-developer-060252892.html">reports it&rsquo;s considering a sale</a>.</li>



<li>Bloom Energy (NYSE:<a href="https://investorplace.com/stock-quotes/be-stock-quote/">BE</a>) shares are heading over 14% higher on a new <a href="https://finance.yahoo.com/news/bloom-energy-coreweave-partner-revolutionize-200500337.html">artificial intelligence (AI) data center partnership</a>.</li>



<li>Immersion (NASDAQ:<a href="https://investorplace.com/stock-quotes/immr-stock-quote/">IMMR</a>) stock is jumping nearly 12% this morning.</li>



<li>Eledon Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/eldn-stock-quote/">ELDN</a>) shares are up more than 11% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Five Below (NASDAQ:<a href="https://investorplace.com/stock-quotes/five-stock-quote/">FIVE</a>) stock is diving over 16% with the <a href="https://www.nasdaq.com/press-release/five-below-inc-announces-ceo-transition-2024-07-16">departure of its CEO</a>.</li>



<li>New Horizon Aircraft (NASDAQ:<a href="https://investorplace.com/stock-quotes/hovr-stock-quote/">HOVR</a>) shares are tumbling more than 13% after <a href="https://www.nasdaq.com/press-release/horizon-aircraft-attend-farnborough-international-airshow-2024-2024-07-15">rallying yesterday on airshow plans</a>.</li>



<li>QXO (NASDAQ:<a href="https://investorplace.com/stock-quotes/qxo-stock-quote/">QXO</a>) stock is taking an over 12% beating on Wednesday morning.</li>



<li>Greenpro Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) shares are sliding more than 12% after <a href="https://www.accesswire.com/888710/greenpro-capital-corp-and-green-x-corp-forms-strategic-alliance-with-bank-islam-trust-company-labuan-ltd">jumping yesterday on strategic alliance news</a>.</li>



<li>Cineverse (NASDAQ:<a href="https://investorplace.com/stock-quotes/cnvs-stock-quote/">CNVS</a>) stock is dropping over 10% on Wednesday.</li>



<li>Virpax Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/vrpx-stock-quote/">VRPX</a>) shares are decreasing almost 10% after rallying yesterday.</li>



<li>Volato (NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/">SOAR</a>) stock is falling more than 9% after a similar rally yesterday.</li>



<li>Eightco (NASDAQ:<a href="https://investorplace.com/stock-quotes/octo-stock-quote/">OCTO</a>) shares are slipping over 9% <a href="https://www.stocktitan.net/news/OCTO/eightco-provides-shareholder-8okhfyrirfyb.html">following a shareholder update</a>.</li>



<li>Xeris Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/xers-stock-quote/">XERS</a>) stock is dipping more than 9% on Wednesday morning.</li>



<li>Logistic Properties of The Americas (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lpa-stock-quote/">LPA</a>) shares close out our pre-market stock movers down 9% after a recent rally.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-july-17th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Greenpro Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) just reported results for the second quarter of 2024.<ul><li>Greenpro Capital reported earnings per share of -7 cents.</li><li>The company reported revenue of $361,174.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/grnq-stock-earnings-greenpro-capital-for-q2-of-2024/">GRNQ Stock Earnings: Greenpro Capital Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

GRNQ Stock Earnings: Greenpro Capital Reported Results for Q2 2024

ADTX

AFAR

APVO

BMRA

ELDN

FIVE

GGTR

GTLB

HOVR

IMMR

LTRY

LXEH

MICS

MLGO

OCTO

PASG

PLTR

SHIM

SISI

SOAR

TANH

VNCE

XERS

Press Releases

Greenpro Capital Corp and Green-X Corp Forms Strategic Alliance with Bank Islam Trust Company (Labuan) Ltd.

GreenX Making Significant Progress on the Establishment of Islamic Digital Asset Exchange in Indonesia

GreenX Sign MOU with Singapore's InvestaX for Strategic Collaboration

GreenX Announce the Upcoming Signing of MOU in Dubai with Sharia Digital Technologies FZ LLC - Dubai and Indonesia PT Digital Syariah Teknologi

GreenX Announce Expansion to Middle East; to set Dubai as Regional Headquarters

Greenpro Capital and Crewstone International Sign Strategic Collaboration MOU

GreenX Approves Listing of KS Digital STO, Pioneering Blockchain Security with Precious Gemstone Resilience

Comments

Greenpro Capital

Greenpro Capital (GRNQ) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga